E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 6
7 / 6Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Review Article

Online Publishing Date:
03 / 08 / 2021

 


Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review

Bagus Setyoboedi, Avianita Dewi Kusumawardhani, Agung Dwi Wahyu Widodo, Muhammad Ilham Aldika Akbar.


Abstract
Vertical transmission is the dominant transmission method in hepatitis B endemic countries. Immunoprophylactic protocols leave 1% to 4% of infants with a higher risk of immunoprophylactic failure. Within the last ten years, publications regarding the use of prenatal Tenofovir disoproxil fumarate (TDF) have been continuously updated. TDF is preferred because of its potency and lower risk of resistance than lamivudine and telbivudine. The studies analyzed in this systematic review consisted of 2 RCT and 7 NRCT studies, involving 3,765 participants. Six studies described a reduction in viral load HBV DNA levels in the intervention group. Furthermore, five studies reported a decrease in the vertical transmission rate higher than the control group, proven with positive HBsAg parameters at newborns in the intervention group. All studies in this systematic review show a reduced risk of immunoprophylactic failure in the intervention group, proven with negative HBsAg and anti-HBs status when infants were 6-12 months old. There were no significant differences between the intervention and control groups in all studies from a safety point of view. Administration of prenatal TDF and the prophylactic protocol can reduce the vertical transmission rate and the risk of immunoprophylactic failure without causing significant adverse effects both during pregnancy and in infants. Given the consideration, the public health sector and physicians should consider TDF prenatal as a complementary treatment to prevent vertical transmission.

Key words: Hepatitis B, Tenofovir disoproxil fumarate, Vertical transmission


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bagus Setyoboedi
Articles by Avianita Dewi Kusumawardhani
Articles by Agung Dwi Wahyu Widodo
Articles by Muhammad Ilham Aldika Akbar
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Setyoboedi B, Kusumawardhani AD, Widodo ADW, Akbar MIA. Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. Int J Med Rev Case Rep. 2021; 5(8): 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal

Web Style

Setyoboedi B, Kusumawardhani AD, Widodo ADW, Akbar MIA. Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. https://www.mdpub.net/?mno=25903 [Access: April 04, 2024]. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal

AMA (American Medical Association) Style

Setyoboedi B, Kusumawardhani AD, Widodo ADW, Akbar MIA. Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. Int J Med Rev Case Rep. 2021; 5(8): 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


Vancouver/ICMJE Style

Setyoboedi B, Kusumawardhani AD, Widodo ADW, Akbar MIA. Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. Int J Med Rev Case Rep. (2021), [cited April 04, 2024]; 5(8): 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


Harvard Style

Setyoboedi, B., Kusumawardhani, . A. D., Widodo, . A. D. W. & Akbar, . M. I. A. (2021) Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. Int J Med Rev Case Rep, 5 (8), 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


Turabian Style

Setyoboedi, Bagus, Avianita Dewi Kusumawardhani, Agung Dwi Wahyu Widodo, and Muhammad Ilham Aldika Akbar. 2021. Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. International Journal of Medical Reviews and Case Reports, 5 (8), 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


Chicago Style

Setyoboedi, Bagus, Avianita Dewi Kusumawardhani, Agung Dwi Wahyu Widodo, and Muhammad Ilham Aldika Akbar. "Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review." International Journal of Medical Reviews and Case Reports 5 (2021), 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


MLA (The Modern Language Association) Style

Setyoboedi, Bagus, Avianita Dewi Kusumawardhani, Agung Dwi Wahyu Widodo, and Muhammad Ilham Aldika Akbar. "Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review." International Journal of Medical Reviews and Case Reports 5.8 (2021), 50-64. Print. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


APA (American Psychological Association) Style

Setyoboedi, B., Kusumawardhani, . A. D., Widodo, . A. D. W. & Akbar, . M. I. A. (2021) Tenofovir Disoproxil Fumarate Prenatal as A Complementary Treatment to Prevent Vertical Transmission of Hepatitis B Virus: A Systematic Review. International Journal of Medical Reviews and Case Reports, 5 (8), 50-64. doi:10.5455/IJMRCR.Tenofovir-Disoproxil-Fumarate-Prenatal


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500